Citation Impact

Citing Papers

Pancreatic Ductal Adenocarcinoma
2012
Inhibition of Phosphatidylinositol 3-Kinase Increases Efficacy of Cisplatin in in Vivo Ovarian Cancer Models
2006
Transforming Growth Factor-β-mediated Signaling via the p38 MAP Kinase Pathway Activates Smad-dependent Transcription through SUMO-1 Modification of Smad4
2003
The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) Study
2012 Standout
Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
2009
Smad transcription factors
2005 Standout
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
2006
Wnt signaling in cancer
2016 Standout
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Pancreatic cancer
2016 Standout
Discovery and characterization of olokizumab
2014
Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products
2020
IL-6 as a keystone cytokine in health and disease
2015 Standout
SUMO
2005 Standout
Pancreatic Adenocarcinoma
2014 Standout
Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation
2004
Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*
2011
Early Biomarker Activity in Severe Sepsis and Septic Shock and a Contemporary Review of Immunotherapy Trials
2013
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Inflammatory Manifestations of Experimental Lymphatic Insufficiency
2006
Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation
2011
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management
2009
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
2014 Standout
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
2017 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout

Works of Fred Faendrich being referenced

Bypass Surgery Versus Palliative Pancreaticoduodenectomy in Patients with Advanced Ductal Adenocarcinoma of the Pancreatic Head, with an Emphasis on Quality of Life Analyses
2006
Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo
2002
Regulation of Biglycan Gene Expression by Transforming Growth Factor-β Requires MKK6-p38 Mitogen-activated Protein Kinase Signaling Downstream of Smad Signaling
2003
Inhibition of Interleukin-6-Transsignaling via gp130-Fc in Hemorrhagic Shock and Sepsis
2008
Age- and gender-related differences of the immune function in a murine model of hemorrhagic shock: IL-10 restores immunodepression in aged females without reduction of mortality
2007
Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach
2018
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1
2003
Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head
2006
Rankless by CCL
2026